Following the release of 2023 improper payment rate data for immunosuppressive drugs, CMS recommends that organizations brush up on compliance tips.Read More »
CMS gave the green light to improved payments for high-cost radiopharmaceuticals and made changes to its payment calculation for cardiac CT services among other updates in the 2025 Outpatient Prospective Payment System (OPPS) final rule.Read More »